Our core competence lies in using the Stan fetal monitor to perform evidence-based ST Analysis of the fetal ECG as an adjunct to cardiotocography (CTG) during childbirth. We are also the provider of disposable fetal scalp electrodes for internal fetal monitoring under the brand Goldtrace. Another important area of business is a comprehensive education and training program, Neoventa Academy, which includes e-learning with certification.
Numerous studies have shown that ST Analysis as an adjunct to CTG during labour reduces the number of babies born with risk of neurological damage, results in fewer operative deliveries, less need for fetal blood sampling and simultaneously being cost effective. The Stan fetal monitor has been used to deliver over one million children since its introduction in Europe. Over 15,000 patients have been enrolled in randomized trials and over 100,000 patients have been enrolled in observational studies.
Neoventa maintains a quality system that is based on the requirements of MDD 93/42/EEC, ISO 13485, ISO 14001 and FDA regulations 21 CFR, Part 820 Quality Systems Regulation.
Neoventa´s quality management system has been assessed and registered by Intertek as conforming to the requirements of SS-EN ISO 13485:2012 and SS-EN ISO 14001:2004.
Our head office is located in Gothenburg, Sweden.